30 closest matches · ranked by relevance
Chronic Pain
Primary: Pain Intensity Difference (PID) at 15 Minutes Post-treatment (PID15) — 0.88; 0.76 Units on scale — p=0.0004
Breakthrough Cancer Pain
Primary: Percentage of Cancer Participants With Breakthrough Cancer Pain From the Total Number of Cancer Participants Seen in Consultation — 14.3 percentage of participants
Cancer
Primary: Summed Pain Intensity Differences (SPID) at 30 Minutes After Dosing (SPID30) — 640.3; 399.6 Units on a scale
Chronic Pain
Primary: Pain Intensity Difference (PID15) At 15 Minutes — 0.82; 0.59 Units on a scale — p=<0.0001
Chronic Pain · Chronic Lower Back Pain · Back Pain
Primary: Changes in Patient Reported Pain and Discomfort — 47; 13; -30; -18 percent change from baseline
Chronic Pain · Opiate Dependence · Lower Back Pain
Primary: Change in Quantitative Pain Testing Following Active TMS Compared to Baseline — 1.4; .3 Change from Baseline (degrees C) — p=.83
Chronic Pain
Primary: Brief Pain Inventory (BPI) Pain Interference Subscale Change — 6.77; 7.31; 7.38; 5.40 units on a scale
Pain, Intractable · Breakthrough Pain · Chronic Pain
Primary: Change From Baseline in the Numerical Rating Pain Scale (NRS) — 1.87; 1.81 units on a scale
Opioid-Related Disorders
Primary: Pain Interference Based on the Brief Pain Inventory — 5.01; 4.67 units on a scale
Labor Pain
Primary: Number of Subjects With Success Rate at 15 Minutes Post-epidural Bolus Injection — 31; 38 Participants — p=0.38
Pain · Cancer
Primary: Percentage of Participants With Adverse Events. — 88.5 percentage of participants
Chronic Low-back Pain
Primary: Assessment of Opioid Use Via Subject Report — 47.5; 21.75 morphine milligram equivalent
Chronic Pain
Primary: Change in the Brief Pain Inventory (BPI) Interference Score From Baseline, Over the 12-month Follow-up Period. — 4.8; 4.5; 5.2 score on a scale — p=0.031
Chronic Non-malignant Pain
Primary: Pain Impact Assessed Using the 4-Item Version of Brief Pain Inventory-Short Form ("PEGS") — 6.485; 6.645; 5.486; 6.210 score on a scale
Healthy Adults
Primary: Quantitative Sensory Threshold Temperature Levels (Degrees Celsius) — .51; 1.08 Degrees Celsius
Chronic Pain
Primary: Daily Opioid Morphine Milligram Equivalents (MME) — 65.17; 67.51 MME/day — p=0.58
Advanced Cancers · Dyspnea
Primary: Retention Rate — 100; 100 percentage of participants
Chronic Pain
Primary: Mean of the Change in Morphine Dosage (in mg) Required to Achieve 25% Reduction in Thermal Evoked Pain Responses Relative to Baseline (Pre-intervention) Placebo…
Pain · Cancer
Primary: Summary of Pain Intensity Differences (SPID) — 47.9; 38.1 Score on a scale — p=0.004
Intractable Pain
Primary: Brief Pain Inventory — 4.5; 5.1 units on a scale — p=.27
Chronic Pain
Primary: Change in Brief Pain Inventory — -1.46 units on a scale
Chronic Pain
Primary: Change in Pain Intensity — -1.61; -1.35 score on a scale — p=0.809
Chronic Pain
Primary: Change in Pain Interference (Micro-level Change) — -1.34; -1.03; -0.50; -0.73 scores on a scale — p=>.05
Chronic Low Back Pain
Primary: Program Initiation (e.g., Reach) — 16; 15 Participants — p=1.0
Sickle Cell Disease
Primary: Patient Reported Outcomes Measurement Information System (PROMIS) Pediatric Short Form Pain Interference Score — 61.5; 62.1; 58.2; 59.4 T-score
Chronic Pain
Primary: Change From Baseline in Average Daily Opioid Dose in Morphine Milligram Equivalents (MME) at Month 12 — -11.6; -6.0 Morphine Milligram Equivalents (MME) — p=0.31
Chronic Pain
Primary: Participants Engaged in the Interventions — 23; 14; 12; 13 Participants
Chronic Pain
Primary: Visual Analog Scale (VAS) for Pain — 46.88; 48.60; 46.76 units on a scale
Opiate Dependence · Chronic Pain
Primary: Pain Intensity — 5.43; 5.92; 5.28; 4.75 units on a scale
Musculoskeletal Pain · Chronic Pain
Primary: Change in Morphine Milligram Equivalent (MME) Average Daily Dose — 8; 4; 5; 5 participants — p=>.05